Literature DB >> 31734345

Bcl-XL: A multifunctional anti-apoptotic protein.

Mingxue Li1, Dun Wang1, Jianhua He1, Lixia Chen2, Hua Li3.   

Abstract

B-cell lymphoma-extra large (Bcl-XL) is one of the anti-apoptotic proteins of the Bcl-2 family that is localized in the mitochondria. Bcl-XL is one of the key regulators of apoptosis that can also regulate other important cellular functions. Bcl-XL is overexpressed in many cancers, and its inhibitors have shown good therapeutic effects. Bcl-XL interacts with Beclin 1, a key factor regulating autophagy. Bcl-XL is essential for the survival of neurons and plays protective roles in neuronal injuries. It can promote the growth of neurons and the correct formation of neural networks, enhance synaptic plasticity, and control neurotoxicity. Bcl-XL can also promote the transport of Ca2+ to mitochondria, increase the production of ATP, and improve metabolic efficiency. In addition, targeting Bcl-XL has shown potential value in autoimmune diseases and aging. In this review, we summarize the functions of Bcl-XL in cancer, autophagy, Ca2+ signaling, neuroprotection, neuronal growth and synaptic plasticity, energy metabolism, immunity, and senescence as revealed by investigations conducted in the past 10 years. Moreover, we list some inhibitors that have been developed based on the functions of Bcl-XL.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bcl-X(L); Cancer; Immunity; Metabolism; Neuroprotection; Senescence

Mesh:

Substances:

Year:  2019        PMID: 31734345     DOI: 10.1016/j.phrs.2019.104547

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  9 in total

1.  Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat.

Authors:  Vijayendran Chandran; Mei-Ling Bermúdez; Mert Koka; Brindha Chandran; Dhanashri Pawale; Ramana Vishnubhotla; Suresh Alankar; Raj Maturi; Balachundhar Subramaniam; Senthilkumar Sadhasivam
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

Review 2.  Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review).

Authors:  Jianfeng He; Danyong Liu; Lixia Zhao; Dongcheng Zhou; Jianhui Rong; Liangqing Zhang; Zhengyuan Xia
Journal:  Exp Ther Med       Date:  2022-05-06       Impact factor: 2.751

3.  Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity.

Authors:  Daniela Melnik; Jayashree Sahana; Thomas J Corydon; Sascha Kopp; Mohamed Zakaria Nassef; Markus Wehland; Manfred Infanger; Daniela Grimm; Marcus Krüger
Journal:  Cells       Date:  2020-02-05       Impact factor: 6.600

4.  Development of Conformational Antibodies to Detect Bcl-xL's Amyloid Aggregates in Metal-Induced Apoptotic Neuroblastoma Cells.

Authors:  Alexis Gonneaud; Fatima-Zohra Fakhir; Emeline Landas; Enora Le Tallec; Elisabeth Chartier-Garcia; Christine Almunia; Alexandre Chenal; Vincent Forge; Christel Marquette
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

Review 5.  Bcl-xL as a Modulator of Senescence and Aging.

Authors:  Cristina Mas-Bargues; Consuelo Borrás; Jose Viña
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 6.  Hypoxia-Inducible Factors and Burn-Associated Acute Kidney Injury-A New Paradigm?

Authors:  Dan Mircea Enescu; Sorin Viorel Parasca; Silviu Constantin Badoiu; Daniela Miricescu; Alexandra Ripszky Totan; Iulia-Ioana Stanescu-Spinu; Maria Greabu; Viorel Jinga
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

7.  A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine.

Authors:  Un-Jung Yun; Su-Jin Bae; Yu-Rim Song; Young-Woo Kim
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 8.  Small-Molecule PROTACs for Cancer Immunotherapy.

Authors:  Zefan Liu; Yajun Zhang; Yucheng Xiang; Xin Kang
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

Review 9.  Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.

Authors:  Zhihui Dou; Dapeng Zhao; Xiaohua Chen; Caipeng Xu; Xiaodong Jin; Xuetian Zhang; Yupei Wang; Xiaodong Xie; Qiang Li; Cuixia Di; Hong Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.